Target Price | €51.21 |
Price | €48.74 |
Potential |
5.06%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target ageas 2025 .
The average ageas target price is €51.21.
This is
5.06%
register free of charge
€58.00
19.00%
register free of charge
€44.00
9.73%
register free of charge
|
|
A rating was issued by 13 analysts: 7 Analysts recommend ageas to buy, 5 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the ageas stock has an average upside potential 2025 of
5.06%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion € | 11.25 | 7.78 |
3.49% | 30.86% | |
Net Margin | 8.49% | 16.74% |
8.65% | 97.12% |
3 Analysts have issued a sales forecast ageas 2024 . The average ageas sales estimate is
This results in the following potential growth metrics:
9 ageas Analysts have issued a net profit forecast 2024. The average ageas net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | 5.19 | 7.07 |
5.46% | 36.22% | |
P/E | 6.89 | |
EV/Sales | 1.86 |
9 Analysts have issued a ageas forecast for earnings per share. The average ageas <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the ageas stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.